Objectives: The aim of this study was to synthesize current evidence on artificial intelligence (AI) adoption in cardiovascular imaging across low- and middle-income countries (LMICs), highlighting diagnostic performance, implementation barriers, and potential solutions.
Methods: We conducted a systematic review of PubMed,
[...] Read more.
Objectives: The aim of this study was to synthesize current evidence on artificial intelligence (AI) adoption in cardiovascular imaging across low- and middle-income countries (LMICs), highlighting diagnostic performance, implementation barriers, and potential solutions.
Methods: We conducted a systematic review of PubMed, Embase, Cochrane Library, Web of Science, and Scopus for studies evaluating AI-based echocardiography, cardiac CT, or cardiac MRI in LMICs. Articles were screened according to PRISMA guidelines, and data on diagnostic outcomes, challenges, and enabling factors were extracted and narratively synthesized.
Results: Twelve studies met the inclusion criteria. AI-driven methods frequently surpassed 90% accuracy in detecting coronary artery disease, rheumatic heart disease, and left ventricular hypertrophy, often enabling task shifting to non-expert operators. Challenges included limited dataset diversity, operator dependence, infrastructure constraints, and ethical considerations. Insights from high-income countries, such as automated segmentation and accelerated imaging, suggest potential for broader AI integration in cardiac MRI and CT.
Conclusions: AI holds promise for enhancing cardiovascular care in LMICs by improving diagnostic accuracy and workforce efficiency. However, multi-center data sharing, targeted training, reliable infrastructure, and robust governance are essential for sustainable adoption. This review underscores AI’s capacity to bridge resource gaps in LMICs, offering practical pathways for future research, clinical practice, and policy development in global cardiovascular imaging.
Full article